Staff Members of FTC have Recommended some Alternative, and more Flexible, Strategies for the Food and Drug Administration to Consider in Regulating Economic Claims Made in Marketing Prescription Drugs to Health Plans and Other Business Entities.

other · 1996-01-01

Source